Genetic polymorphisms of MPO, GSTT1, GSTM1, GSTP1, EPHX1 and NQO1 as risk factors of early-onset lung cancer

International Journal of Cancer

Volumn 127, Issue 7, 2010, Pages 1547-1561

  Timofeeva, Maria ^a   Kropp, Silke ^a   Sauter, Wiebke ^b   Beckmann, Lars ^a   Rosenberger, Albert ^c   Illig, Thomas ^b   Jäger, Birgit ^a   Mittelstrass, Kirstin ^b   Dienemann, Hendrik ^d   Bartsch, Helmut ^a   Bickeböller, Heike ^c   Chang Claude, Jenny ^a   Risch, Angela ^a   Wichmann, Heinz Erich ^b,e,f   Kleen, Heidi ^g   Bonnet, R ^h   Ko, ^h   Geisen, ^h   Stier, ⁱ   Ukena, D ^j   Penzl, ^j   Schmidt, ^k,l   Jielge, ^k   Hoffken ^l   Hamm, ^m   Pfeifer, ⁿ   Bultzingslowen ⁿ   Schneider, ⁿ   Teschler, ^o   Fischer, ^o   Haubinger ^p   Thetter, ^p   Dull ^p   Wagner, ^p   Heil, ^q   Tauscher ^q   Lange, ^q   Trumper ^r   Griesinger, ^r   Overbeck, ^r   Schondube ^s   Danner, ^s   Fleischer, ^t   Morr, ^u   Degen, M ^u   Matter, ^u   Ewert, ^v   Altesellmeier, ^v   Schonhofer ^w   Kohlaussen ^w   Drings, ^x   Herrmann, ^x   Kaiser, ^y   Sybrecht, ^z   Groschel ^z   Mack, ^z   Andreas, ^aa   Rittmeyer, ^aa   Stolben ^ab   Wolf, ^ac   Staratschek Jox, ^ac   Gillisen, ^ad   Cebulla, ^ad   Kreymborg, ^ae   Criee ^f   Korber ^f   Knaack, ^f   Huber, ^f   Borgmeier, ^f   Keppler, ^af   Schafer ^af   Schaberg, ^ag   Struss ^ag   Wiesholzer, M ^a   more..

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

^d Thoraxklinik   (Germany)

^e UNIVERSITY OF MUNICH   (Germany)

^f LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^g Zentralklinik Bad Berka GmbH ^*

^h Johanniter Krankenhaus   (Germany)

ⁱ UNIVERSITY OF BONN   (Germany)

^j KLINIKUM CHEMNITZ   (Germany)

^k Fachkrankenhaus Coswig   (Germany)

^l Kreiskrankenhaus Diekholzen   (Germany)

^m Kreiskrankenhaus Diekholzen   (Germany)

ⁿ RUHRLANDKLINIK   (Germany)

^o ASKLEPIOS FACHKLINIKEN MÜNCHEN GAUTING   (Germany)

^p Wald Klinikum Gera   (Germany)

^q Abteilung Onkologie   (Germany)

^r Abteilung Onkologie   (Germany)

^s Sleep Laboratory   (Germany)

^t Pneumologische Klinik   (Germany)

^u TECHNICAL UNIVERSITY OF BRAUNSCHWEIG   (Germany)

^v Klinikum Hannover Oststadt   (Germany)

^w Diakoniekrankenhaus Henriettenstiftung GGmbH   (Germany)

^x ST BERNWARD KRANKENHAUS   (Germany)

^y SAARLAND UNIVERSITY   (Germany)

^z Fachklinik fur Lungenerkrankungen   (Germany)

^aa KRANKENHAUS MERHEIM   (Germany)

^ab UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^ac Robert Koch Klinik   (Germany)

^ad UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^ae Abt Pneumologie   (Germany)

^af Diakoniekrankenhaus Rotenburg   (Germany)

^ag I Medizinische Abteilung   (Austria)

more..

Author keywords

Detoxifying enzymes; Early onset; Genetic polymorphisms; Lung cancer

Indexed keywords

EPOXIDE HYDROLASE; GLUTATHIONE TRANSFERASE; MYELOPEROXIDASE; PROTEIN SUBUNIT; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; GLUTATHIONE TRANSFERASE P1; NQO1 PROTEIN, HUMAN; PEROXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE);

ADULT; AGE; ARTICLE; CANCER CONTROL; CANCER RISK; CASE CONTROL STUDY; CAUCASIAN; DISEASE ASSOCIATION; EARLY CANCER; FEMALE; GENDER; GENETIC SCREENING; GENOTYPE; HEREDITY; HUMAN; INCIDENCE; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; OBSERVATION; PRIMARY TUMOR; PRIORITY JOURNAL; RARE DISEASE; RISK FACTOR; SEX; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; ENZYMOLOGY; GENE DELETION; GENETIC POLYMORPHISM; GENETICS; HETEROZYGOTE; INTRON; LUNG TUMOR; MIDDLE AGED; ONSET AGE; PROMOTER REGION;

AGE OF ONSET; CARRIER STATE; FEMALE; GENOTYPE; GLUTATHIONE S-TRANSFERASE PI; HUMANS; INTRONS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NAD(P)H DEHYDROGENASE (QUINONE); PEROXIDASE; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RISK FACTORS; SEQUENCE DELETION; SMOKING;

EID: 77956576471     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25175     Document Type: Article

References (40)

1. Gadgeel SM, Ramalingam S, Cummings G, Kraut MJ, Wozniak AJ, Gaspar LE, Kalemkerian GP. Lung cancer in patients <50 years of age: the experience of an academic multidisciplinary program. Chest 1999;115:1232-6.
2. Radzikowska E, Roszkowski K, Glaz P. Lung cancer in patients under 50 years old. Lung Cancer 2001;33:203-11.
3. Ramalingam S, Pawlish K, Gadgeel S, Demers R, Kalemkerian GP. Lung cancer in young patients: analysis of a Surveillance, Epidemiology, and End Results database. J Clin Oncol 1998;16:651-7.
4. Ak G, Metintas M, Metintas S, Yildirim H, Erginel S, Alatas F. Lung cancer in individuals less than 50 years of age. Lung 2007;185:279-86.
5. Etzel CJ, Lu M, Merriman K, Liu M, Vaporciyan A, Spitz MR. An epidemiologic study of early onset lung cancer. Lung Cancer 2006;52:129-34.
6. Liu NS, Spitz MR, Kemp BL, Cooksley C, Fossella FV, Lee JS, Hong WK, Khuri FR. Adenocarcinoma of the lung in young patients: the M. D. Anderson experience. Cancer 2000;88:1837-41.
7. Kreuzer M, Kreienbrock L, Gerken M, Heinrich J, Bruske-Hohlfeld I, Muller KM, Wichmann HE. Risk factors for lung cancer in young adults. Am J Epidemiol 1998;147:1028-37.
8. Taioli E, Gaspari L, Benhamou S, Boffetta P, Brockmoller J, Butkiewicz D, Cascorbi I, Clapper ML, Dolzan V, Haugen A, Hirvonen A, Husgafvel-Pursiainen K, et al. Polymorphisms in CYP1A1, GSTM1, GSTT1 and lung cancer below the age of 45 years. Int J Epidemiol 2003;32:60-3.
9. Cote ML, Wenzlaff AS, Bock CH, Land SJ, Santer SK, Schwartz DR, Schwartz AG. Combinations of cytochrome P-450 genotypes and risk of early-onset lung cancer in Caucasians and African Americans: a population-based study. Lung Cancer 2007;55:255-62.
10. Li X, Hemminki K. Inherited predisposition to early onset lung cancer according to histological type. Int J Cancer 2004;112:451-7. (Pubitemid 39390610)
11. Kreuzer M, Kreienbrock L, Muller KM, Gerken M, Wichmann E. Histologic types of lung carcinoma and age at onset. Cancer 1999;85:1958-65.
12. Gemignani F, Landi S, Szeszenia-Dabrowska N, Zaridze D, Lissowska J, Rudnai P, Fabianova E, Mates D, Foretova L, Janout V, Bencko V, Gaborieau V, et al. Development of lung cancer before the age of 50: the role of xenobiotic metabolizing genes. Carcinogenesis 2007;28:1287-93.
13. Graziano C, Comin CE, Crisci C, Novelli L, Politi L, Messerini L, Andreani M, Porfirio B. Functional polymorphisms of the microsomal epoxide hydrolase gene: a reappraisal on a early-onset lung cancer patients series. Lung Cancer 2009;63:187-93.
14. Rosenberger A, Illig T, Korb K, Klopp N, Zietemann V, Wolke G, Meese E, Sybrecht G, Kronenberg F, Cebulla M, Degen M, Drings P, et al. Do genetic factors protect for early onset lung cancer? A case control study before the age of 50 years. BMC Cancer 2008;8:60.
15. Mittelstrass K, Sauter W, Rosenberger A, Illig T, Timofeeva M, Klopp N, Dienemann H, Meese E, Sybrecht G, Woelke G, Cebulla M, Degen M, et al. Early onset lung cancer, cigarette smoking and the SNP309 of the murine double minute-2 (MDM2) gene. BMC Cancer 2008;8:113.
16. Sauter W, Rosenberger A, Beckmann L, Kropp S, Mittelstrass K, Timofeeva M, Wolke G, Steinwachs A, Scheiner D, Meese E, Sybrecht G, Kronenberg F, et al. Matrix metalloproteinase 1 (MMP1) is associated with early-onset lung cancer. Cancer Epidemiol Biomarkers Prev 2008;17:1127-35.
17. Timofeeva MN, Kropp S, Sauter W, Beckmann L, Rosenberger A, Illig T, Jager B, Mittelstrass K, Dienemann H, The LUCY-Consortium, Bartsch H, Bickeboller H, et al. CYP450 polymorphisms as risk factors for early-onset lung cancer: gender-specific differences. Carcinogenesis 2009;30:1161-9.
18. Dally H, Edler L, Jager B, Schmezer P, Spiegelhalder B, Dienemann H, Drings P, Schulz V, Kayser K, Bartsch H, Risch A. The CYP3A4*1B allele increases risk for small cell lung cancer: effect of gender and smoking dose. Pharmacogenetics 2003;13:607-18.
19. Holle R, Happich M, Lowel H, Wichmann HE. KORA - a research platform for population based health research. Gesundheitswesen 2005;67 (Suppl 1): S19-S25.
20. HapMap Data Rel 20/phaseII, on NCBI B35 assebbly, db SNPb125. HapMap, 2006. Available at http://hapmap.ncbi.nlm.nih.gov/index.html.en
21. Vollmert C, Windl O, Xiang W, Rosenberger A, Zerr I, Wichmann HE, Bickeboller H, Illig T, Kretzschmar HA. Significant association of a M129V independent polymorphism in the 5′ UTR of the PRNP gene with sporadic Creutzfeldt-Jakob disease in a large German case-control study. J Med Genet 2006;43:e53.
22. Timofeeva M, Jager B, Rosenberger A, Sauter W, Wichmann HE, Bickeboller H, Risch A. A multiplex real-time PCR method for detection of GSTM1 and GSTT1 copy numbers. Clin Biochem 2009;42:500-9.
23. Gauderman WJ. Sample size requirements for matched case-control studies of gene-environment interaction. Stat Med 2002;21:35-50. (Pubitemid 34065703)
24. Purcell S. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007;81:559-75.
25. PLINK 1.07 [computer program]. Available at http://pngu.mgh.harvard.edu/ purcell/plink/
26. Bruhn C, Brockmoller J, Kerb R, Roots I, Borchert HH. Concordance between enzyme activity and genotype of glutathione S-transferase theta (GSTT1). Biochem Pharmacol 1998;56:1189-93.
27. Seidegard J, Pero RW. The hereditary transmission of high glutathione transferase activity towards trans-stilbene oxide in human mononuclear leukocytes. Hum Genet 1985;69:66-8. (Pubitemid 15153915)
28. Sorensen M, Raaschou-Nielsen O, Brasch-Andersen C, Tjonneland A, Overvad K, Autrup H. Interactions between GSTM1, GSTT1 and GSTP1 polymorphisms and smoking and intake of fruit and vegetables in relation to lung cancer. Lung Cancer 2007;55:137-44.
29. Houlston RS. Glutathione S-transferase M1 status and lung cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 1999;8:675-82.
30. Benhamou S, Lee WJ, Alexandrie AK, Boffetta P, Bouchardy C, Butkiewicz D, Brockmoller J, Clapper ML, Daly A, Dolzan V, Ford J, Gaspari L, et al. Meta- and pooled analyses of the effects of glutathione S-transferase M1 polymorphisms and smoking on lung cancer risk. Carcinogenesis 2002;23:1343-50.
31. Ye Z, Song H, Higgins JP, Pharoah P, Danesh J. Five glutathione s-transferase gene variants in 23,452 cases of lung cancer and 30,397 controls: meta-analysis of 130 studies. PLoS Med 2006;3:e91.
32. Carlsten C, Sagoo GS, Frodsham AJ, Burke W, Higgins JP. Glutathione S-transferase M1 (GSTM1) polymorphisms and lung cancer: a literature-based systematic HuGE review and meta-analysis. Am J Epidemiol 2008;167:759-74.
33. Raimondi S, Paracchini V, Autrup H, Barros-Dios JM, Benhamou S, Boffetta P, Cote ML, Dialyna IA, Dolzan V, Filiberti R, Garte S, Hirvonen A, et al. Meta- and pooled analysis of GSTT1 and lung cancer: a HuGE-GSEC review. Am J Epidemiol 2006;164:1027-42.
34. Mitrunen K, Hirvonen A. Molecular epidemiology of sporadic breast cancer. The role of polymorphic genes involved in oestrogen biosynthesis and metabolism. Mutat Res 2003;544:9-41.
35. Moyer AM, Salavaggione OE, Wu TY, Moon I, Eckloff BW, Hildebrandt MA, Schaid DJ, Wieben ED, Weinshilboum RM. Glutathione s-transferase p1: gene sequence variation and functional genomic studies. Cancer Res 2008;68:4791-801.
36. Kim SG, Kim YH. Gender-related expression of rat microsomal epoxide hydrolase during maturation: post-transcriptional regulation. Mol Pharmacol 1992;42:75-81.
37. Chanas B, Wang H, Ghanayem BI. Differential metabolism of acrylonitrile to cyanide is responsible for the greater sensitivity of male vs female mice: role of CYP2E1 and epoxide hydrolases. Toxicol Appl Pharmacol 2003;193:293-302.
38. Gaikwad NW, Rogan EG, Cavalieri EL. Evidence from ESI-MS for NQO1-catalyzed reduction of estrogen orthoquinones. Free Radic Biol Med 2007;43:1289-98.
39. Chandrasena RE, Edirisinghe PD, Bolton JL, Thatcher GR. Problematic detoxification of estrogen quinones by NAD(P)H-dependent quinone oxidoreductase and glutathione-S-transferase. Chem Res Toxicol 2008;21:1324-9.
40. Montano MM, Chaplin LJ, Deng H, Mesia-Vela S, Gaikwad N, Zahid M, Rogan E. Protective roles of quinone reductase and tamoxifen against estrogen-induced mammary tumorigenesis. Oncogene 2007;26:3587-90.